Meet our Newest Members

New members

RAREly Solutions helps early-stage biotech and rare-disease innovators turn breakthrough science into investable, scalable companies.

New members

Multi-family office advising €5B in assets, iVESTA empowers entrepreneurs to manage wealth with transparency, impact, and aligned interests.

New members

A digital health platform improving cancer patient follow-up and care while enabling real-world research on innovative therapies.

Members

Proud to welcome Alexion, a pioneer in rare disease treatments, as a new FACCNE Elite Member.

New members

WeeFin joins FACCNE! Discover their ESG Connect platform, empowering investors to make smarter, more sustainable financial decisions.

New members

We are delighted to welcome Yuma AI, the most advanced AI platform built specifically for e-commerce, to the FACCNE network.

New members

A premier litigation firm delivering creative, high-value solutions for global clients across complex, high-stakes legal challenges.

New members

Goossaert Law helps innovation-driven companies navigate complex digital regulations and turn legal risks into strategic opportunities.

New members

Connecting businesses and customers worldwide, Quadient joins FACCNE to drive innovation in communication and customer experience.

New members

We’re thrilled to welcome Servier Pharmaceuticals as a Platinum Member of FACCNE, partnering to drive innovation, collaboration, and lasting impact!

New members

Leading the way in Life Sciences consulting, HORIANA delivers expert support in data science, epidemiology, and real-world evidence studies.

New members

Revolutionizing cancer treatment through groundbreaking Leptin/NRP-1/OBR-targeted immunotherapies, led by its First-in-Class antibody, NOV2.